The "Chinese Multidisciplinary Expert Consensus on the Prevention and Treatment of Diabetic Eye Disease (2021 Edition)" highlights the significant impact of diabetic eye diseases on patients' quality of life in China and stresses the importance of collaboration between endocrinologists and ophthalmologists. It updates the 2018 guidelines on diabetic retinopathy (DR) and covers related conditions like cataracts and corneal disease. Key recommendations include regular DR screenings, timely ophthalmologist referrals, and effective management of blood sugar, blood pressure, and lipids. The consensus also emphasizes the role of artificial intelligence in screening and the need for personalized treatment plans, particularly for cataract surgery and corneal health, aiming to enhance management and reduce blindness risk among diabetic patients.